Drug intelligence / Profile preview

Dextro Combo

Development stage
Unknown
Lead developer
Hizon Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

Dextro Combo is a multi-ingredient pharmaceutical product typically formulated for the symptomatic relief of the common cold, allergic rhinitis, and non-productive cough. It most commonly refers to a fixed-dose combination of dextromethorphan hydrobromide (an antitussive), phenylephrine hydrochloride (a nasal decongestant), and chlorpheniramine maleate (an antihistamine). Dextromethorphan acts centrally on the cough center in the medulla to elevate the cough threshold. Phenylephrine is a selective alpha-1 adrenergic receptor agonist that induces vasoconstriction in the respiratory tract mucosa, thereby reducing swelling and congestion. Chlorpheniramine is a first-generation H1-receptor antagonist that alleviates allergic symptoms such as sneezing, itching, and rhinorrhea. While primarily available as an over-the-counter (OTC) medication in various international markets, the name is also occasionally used in veterinary medicine for dextrose-based electrolyte solutions.

Brand names
Dextro Combo
Other names
Dextromethorphan + Phenylephrine + Chlorpheniramine
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)SIGMAR1 (Sigma non-opioid intracellular receptor 1)ADRA1A (α1A)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Dextro Combo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dextro Combo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call